Godavari Drugs share news and announcements
BSE: 530317Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹124.15.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹122 Cr3,042nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 29.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 1.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 7.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 1.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,422
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Godavari Drugs quarterly results
The board met on 14 Aug 2026 to consider quarterly results
Notice filed 10 Aug 2026
Godavari Drugs annual reports, presentations and earnings calls
The company's own documents, latest first.Godavari Drugs financials, year by year
Annual reports29
- Annual report, year to Mar 2026 (opens in a new tab)1 Sep 2026
- Annual report, year to Mar 2025 (opens in a new tab)3 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)5 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)21 Jul 2023
- Annual report, year to Mar 2022 (opens in a new tab)25 Apr 2022
24 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)22 Jul 2021
- Annual report, year to Mar 2020 (opens in a new tab)24 Jul 2020
- Annual report, year to Mar 2019 (opens in a new tab)9 Aug 2019
- Annual report, year to Mar 2018 (opens in a new tab)28 Aug 2018
- Annual report, year to Mar 2017 (opens in a new tab)20 Sep 2017
- Annual report, year to Mar 2016 (opens in a new tab)2 Sep 2016
- Annual report, year to Mar 2015 (opens in a new tab)21 Jul 2015
- Annual report, year to Mar 2014 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2013 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2012 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2011 (opens in a new tab)19 Dec 2011
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1997 (opens in a new tab)Filing day not known
Godavari Drugs share news and announcements
547 announcements, routine notices left out, newest first. Page 1 of 11.
Oct 2026
16 Oct · Intimation Regarding Change In The Corporate Identification Number (CIN) Of The Company Consequent Upon Alteration Of The Object Clause Of The Memorandum Of Association
Sep 2026
3 Sep · Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) Regulations
1 Sep · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Aug 2026
14 Aug · Announcement under Regulation 30 (LODR)-Allotment
10 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
May 2026
27 May · Business
22 May · Board meeting
Meeting on 27 May 2026: audited results and quarterly results
Apr 2026
17 Apr · Legal
Exchange has sought clarification from Godavari Drugs Ltd on April 17, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Mar 2026
18 Mar · Board meeting
Feb 2026
12 Feb · Meeting
9 Feb · Board meeting
Meeting on 11 Feb 2026: quarterly results
Jan 2026
21 Jan · Meeting
15 Jan · Business
15 Jan · Board meeting
12 Jan · Board meeting
Meeting on 15 Jan 2026: preferential issue of shares8 Jan · Legal
Exchange has sought clarification from Godavari Drugs Ltd on January 07, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 29 Sep 2025Board or managers changedup 0.15%0.0 pts vs Nifty 500market median 0.0% · five sessions +0.1% (−1.9 pts vs Nifty 500) · volume 1.3× usual · The announcement (opens in a new tab)
- 30 May 2025Board or managers changeddown 10.96%−10.7 pts vs Nifty 500market median 0.0% · five sessions −13.4% (−13.7 pts vs Nifty 500) · volume 12.5× usual · The announcement (opens in a new tab)
- 14 Aug 2023Board or managers changeddown 2.83%−2.6 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−4.9 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 16 Mar 2023Board or managers changedup 0.86%+0.8 pts vs Nifty 500market median 0.0% · five sessions +3.3% (+2.3 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 15 Feb 2023Board or managers changedup 1.54%+1.1 pts vs Nifty 500market median 0.0% · five sessions +10.4% (+10.8 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 14 Feb 2023Board or managers changeddown 9.94%−10.4 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+2.5 pts vs Nifty 500) · volume 2.4× usual · The announcement (opens in a new tab)
- 8 Feb 2023Board or managers changedup 1.89%+1.0 pts vs Nifty 500market median 0.0% · five sessions −11.6% (−12.1 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 14 Nov 2022Board or managers changeddown 2.18%−2.2 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−5.4 pts vs Nifty 500) · volume 2.0× usual · The announcement (opens in a new tab)
- 20 Apr 2022Board or managers changedup 1.36%+0.5 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.3 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 13 Nov 2019Board or managers changeddown 1.59%−0.9 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−1.3 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
3 earlier announcements
- 7 Sep 2017Board or managers changedup 0.94%+0.3 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−2.6 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 20 May 2013Dividendup 4.44%+5.0 pts vs Nifty 500market median 0.0% · five sessions +1.4% (+4.9 pts vs Nifty 500) · volume 0.4× usual
- 27 Mar 2012Board or managers changedup 4.82%+7.2 pts vs Nifty 500market median 0.0% · five sessions +9.6% (+11.4 pts vs Nifty 500) · volume 0.0× usual